What Patients Need to Know About Lung Cancer Research in the Era of COVID-19


The newest episode of Lung Cancer Considered, the IASLC's official podcast program, features patient advocates and lung cancer researchers on what patients need to know about lung cancer research in the era of COVID-19. This episode features a conversation between Janet Freeman-Daily, writer, lung cancer patient, advocate and Twitter chat moderator of the Lung Cancer Social Media chat (#LCSMchat); Jill Feldman, lung cancer advocate and patient; Dr. Alice Berger, assistant professor of human biology at the Fred Hutchinson Cancer Research Center; Dr. Christine Lovly, associate professor of medicine, division of Hematology and Oncology and Ingram Associate Professor of Cancer Research at Vanderbilt University Medical Center; Dr. Brendon Stiles, associate professor of cardiothoracic surgery at Weill Cornell Medical College, Cornell University, and the associate attending cardiothoracic surgeon at New York Presbyterian Hospital; Dr. Amy Moore has experience as a cancer researcher as director of science and research at the GO2 Foundation for Lung Cancer; Dr Upal Basu Roy also has experience as a cancer researcher as vice president of research at LUNGevity Foundation; and Dr Jan Baranski, vice president of scientific and patient programs for the Lung Cancer Research Foundation.

Jill Feldman
Jill Feldman
EGFR Resisters
Department of Defense Lung Cancer Research Program
Christine Lovly
Christine Lovly


Associate Professor of Medicine, Division of Hematology-Oncology
Vanderbilt University Medical Center
Vanderbilt Ingram Cancer Center
Member Story: Dr. Amy Moore
Amy Moore
VP, Global Engagement and Patient Partnerships
LUNGevity Foundation

Other Podcast

LCC in French Canadian
KRAS in NSCLC: Beyond G12C